Virtus LifeSci Valuation Overview

BBP -- USA Etf  

USD 43.41  0.42  0.96%

Virtus LifeSci Biotech has current Real Value of $43.68 per share. The regular price of the etf is $43.41. At this time the etf appears to be fairly valued. Macroaxis measures value of Virtus LifeSci Biotech from inspecting the etf fundamentals such as Number of Employees of 12, Net Asset of 34.16M and Price to Earning of 18.03times as well as reviewing its technical indicators and Probability Of Bankruptcy. In general, we recommend to buy undervalued stocks and to dispose of overvalued stocks since at some point securities prices and their ongoing real values will draw towards each other.
Horizon     30 Days    Login   to change
Virtus LifeSci Biotech Products ETF is third largest ETF in price to sales as compared to similar ETFs. It is rated below average in price to earning as compared to similar ETFs reporting about  3.22  of Price to Earning per Price to Sales.

Current Market Valuation

Virtus LifeSci Biotech Valuation Boundaries

Fairly Valued
September 18, 2018
43.41
Market Value
43.68
Real Value
Target Odds
  
46.23
Upside
Virtus LifeSci is not too risky asset. Calculation of real value of Virtus LifeSci Biotech is based on 1 month time horizon. Increasing Virtus LifeSci Biotech time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Check also Trending Equities. Please also try Money Flow Index module to determine momentum by analyzing money flow index and other technical indicators.
Search macroaxis.com